Alerts
Home > Research & Clinical Trials > Clinical Trials at Avera > Clinical Trials Search Results
Sorted By:
Prospective, multi-center, double-blind, randomized, controlled trial evaluating nirmatrelvir/ritonavir (Paxlovid) in two dosing durations for the treatment of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC).